Add BrightSurf on Google Email

Atrial fibrillation after surgery is linked to an increased risk of hospitalization for heart failure

A study of over three million patients found that post-operative atrial fibrillation increases the risk of hospitalization for heart failure. The risk is present regardless of whether surgery was performed for a heart condition, and can be as high as doubling in non-heart-related conditions.

SourceEuropean Society of Cardiology·JournalEuropean Heart Journal·TypeObservational study·DateJun 28, 2022

University of Maryland School of Medicine researchers publish findings of first successful transplant of genetically modified pig heart into human patient

Researchers at the University of Maryland School of Medicine conducted a groundbreaking xenotransplant surgery, implanting a genetically modified pig heart into a 57-year-old patient with terminal heart disease. The patient survived for two months with a strong functioning heart showing no obvious signs of rejection.

SourceUniversity of Maryland School of Medicine·JournalNew England Journal of Medicine·TypeCase study·DateJun 22, 2022

Lack of diversity of microorganisms in the gut or elevated metabolite implicated in heart failure severity

A systematic review found that reduced gut microbiome diversity and elevated trimethylamine-N-oxide (TMAO) metabolite levels are associated with increased risk of death and hospital visits in heart failure patients. Further research on the impact of diet and potential interventions is underway.

SourceGeorgetown University Medical Center·JournalHeart Failure Reviews·TypeLiterature review·DateJun 20, 2022

Heart failure patients unvaccinated against COVID-19 are three times more likely to die from it than boosted heart failure patients

A new study from Mount Sinai Heart found that heart failure patients unvaccinated against COVID-19 are three times more likely to die from it than those who are fully vaccinated and boosted. The research also shows that these unvaccinated patients face higher risks of hospitalization and ICU admission if infected with the virus.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalJournal of Cardiac Failure·TypeObservational study·DateJun 9, 2022

Long-term study finds cigarette smoking doubled risk of developing heart failure

A long-term study found that cigarette smoking significantly increases the risk of developing both reduced ejection fraction and preserved ejection fraction heart failure. Former smokers retained a higher risk of heart failure for decades after quitting, with the risk decreasing only after 30 years without smoking.

SourceJohns Hopkins Bloomberg School of Public Health·JournalJournal of the American College of Cardiology·DateJun 7, 2022

COVID-19's toll on global cardiac services - UK Version

A major international study reveals the significant impact of COVID-19 on cardiovascular services worldwide, with a substantial decline in hospital admissions and increased mortality rates. The study warns that problems with heart health will continue to accrue unless mitigation strategies are implemented quickly.

SourceUniversity of Leeds·JournalEuropean Heart Journal·TypeSystematic review·DateMay 30, 2022

Contraceptive counseling and provision in clinical practice increases its use and reduces unintended pregnancy

A review of 38 randomized controlled trials found that counseling patients about contraceptive use and providing contraceptives increases use without increasing STI risk or reducing condom use. The interventions also decrease unintended pregnancy in trials designed to evaluate this outcome.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeMeta-analysis·DateMay 23, 2022

How MRI could revolutionise heart failure diagnosis

A new study published in the European Heart Journal shows that MRI is superior to echocardiography for diagnosing heart failure and predicting patient outcomes. The research found that MRI can accurately measure left ventricular filling pressure, leading to improved diagnosis and reduced need for invasive assessments.

SourceUniversity of East Anglia·JournalEuropean Heart Journal·TypeObservational study·DateMay 4, 2022

Risk score seems to accurately identify patients at low risk for syncope in Emergency Department

A new study validates the Canadian Syncope Risk Score as a reliable tool to identify patients at low risk for serious outcomes after 30 days, potentially reducing hospitalization rates. The score showed better performance than another validated score, but its clinical utility remains uncertain and warrants further research.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeObservational study·DateApr 25, 2022

The recovery process after a heart attack

A recent study published in Molecular Therapy Nucleic Acids found that the molecule urocortin-2 may regulate recovery processes after a heart attack by modulating miR-29a. Treatment with urocortin-2 could favor patient recovery by regulating apoptosis and fibrosis.

SourceUniversity of Seville·JournalMolecular Therapy — Nucleic Acids·DateApr 5, 2022

Electronic alert improves guideline adherence for heart failure treatment

A new study found that customized digital alerts via an electronic health record system significantly increased the number of guideline-directed medications prescribed for heart failure patients. The alerts improved medication use by over a quarter of patients, translating to one medication addition per every 14 alerts received.

SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·DateApr 3, 2022

Cutting salt intake shows some benefits for people with heart failure

The SODIUM-HF trial found that reducing sodium intake for one year improved quality of life and slowed heart failure progression in patients. However, it did not significantly reduce major adverse events or hospitalizations. The study suggests that individualized recommendations may be beneficial for certain patients.

SourceAmerican College of Cardiology·JournalThe Lancet·TypeRandomized controlled/clinical trial·DateApr 2, 2022

Hold the salt: Study reveals how reducing sodium intake can help patients with heart failure

A study of 806 patients with heart failure found that reducing sodium intake improved symptoms such as swelling, fatigue, and coughing. However, it had no effect on rates of death, hospitalization, or emergency department visits. The researchers recommend a lower sodium intake limit for heart failure patients.

SourceUniversity of Alberta·JournalThe Lancet·TypeRandomized controlled/clinical trial·DateApr 2, 2022

ACC, AHA, HFSA issue heart failure guideline

The new ACC/AHA/HFSA guideline redefines heart failure stages to focus on prevention, updating treatment options for people with symptomatic heart failure. It recommends blood pressure control, SGLT-2 inhibitor medicines, and healthy lifestyle habits to prevent HF risk factors from developing.

SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·TypeLiterature review·DateApr 1, 2022

Molecular pathway driving maladaptive processes in heart failure elucidated by scientists at Lewis Katz School of Medicine at Temple University, opening door to new therapeutic strategies

Researchers at Lewis Katz School of Medicine at Temple University discover a molecular pathway driving maladaptive processes in heart failure, revealing the importance of GRK5's catalytic activity and nuclear presence. The study opens doors to new therapeutic strategies for treating this devastating condition.

SourceTemple University Health System·JournalJournal of the American College of Cardiology·DateMar 15, 2022

Chronic lactate exposure leads to cellular disruptions implicated in cancer and possibly T2 diabetes

Researchers found that chronic lactate exposure can lead to cellular disruptions, decreased fatty acid transport, and alterations of mitochondrial membranes, which may contribute to the development of heart failure and type 2 diabetes. The study suggests that lactate accumulation could be a major player in disease progression.

SourceUniversity of Colorado Anschutz Medical Campus·JournalFrontiers in Nutrition·TypeMeta-analysis·DateMar 10, 2022

Salt in soluble paracetamol linked to increase risk of cardiovascular disease and death

A large study found a significant link between salt-containing paracetamol and an increased risk of heart attacks, stroke, and death. Patients with high blood pressure who took sodium-containing paracetamol had a higher risk of cardiovascular disease and death compared to those taking non-sodium-containing paracetamol.

SourceEuropean Society of Cardiology·JournalEuropean Heart Journal·TypeObservational study·DateFeb 23, 2022

Black heart disease: Two elevated biomarkers distinguish Blacks with resistant hypertension from Whites

Researchers found elevated plasma xanthine oxidase activity and more fragments of damaged mitochondrial DNA in Black adults with resistant hypertension compared to white adults. These findings suggest an important underlying cause of increased cardiovascular risk in Blacks with difficult-to-treat hypertension.

SourceUniversity of Alabama at Birmingham·JournalHypertension·TypeCase study·DateFeb 23, 2022

Scientists characterize the imbalanced gut bacteria of patients with myocardial infarction, angina and heart failure

Researchers analyzed the gut microbiome of 1,241 middle-aged individuals and found that about half of the bacterial species were modified by drug treatment, while 75% of disturbances occurred in early stages of overweight and type 2 diabetes. The study suggests that an imbalanced gut microbiome may play a role in heart disease development

'Bionic' pacemaker reverses heart failure

A new 'bionic' pacemaker is being developed to restore the natural variability of the heartbeat, which has been found to improve cardiac output by 20%. This innovation could revolutionize the treatment of heart failure in New Zealand patients.

SourceUniversity of Auckland·JournalBasic Research in Cardiology·TypeRandomized controlled/clinical trial·DateFeb 7, 2022

Calcium: important not just for your bones but also for your heart

A recent study published in Science Translational Medicine identified a novel causative gene, BAG5, for dilated cardiomyopathy, a leading cause of heart failure. The researchers found that mutations in this gene can lead to cardiomyopathy and found a potential treatment alternative using adeno-associated viruses (AAV) gene therapy.

SourceOsaka University·JournalScience Translational Medicine·TypeExperimental study·DateJan 19, 2022

The circadian clock in heart failure

A study by Baylor College of Medicine found that Rev-erbα/β in cardiomyocytes mediates a normal metabolic rhythm, enabling the cells to use lipids as energy during resting time. Removing Rev-erbα/β disrupts this rhythm, leading to progressive dilated cardiomyopathy and lethal heart failure.

SourceBaylor College of Medicine·JournalCirculation·TypeExperimental study·DateJan 17, 2022